5 Most Profitable Value Stocks to Buy Right Now

4. Amgen Inc. (NASDAQ:AMGN)

Amgen Inc. (NASDAQ:AMGN) is one of the most profitable value stocks to buy right now. On April 6, Amgen announced positive topline results from a Phase 3 trial evaluating a subcutaneous formulation of TEPEZZA for patients with moderate-to-severe active Thyroid Eye Disease. The study used an on-body injector to deliver the medicine every two weeks, demonstrating efficacy comparable to the currently approved intravenous/IV version.

The trial successfully met its primary endpoint, with 77% of participants achieving a significant proptosis response (a reduction in eye bulging) compared to ~20% in the placebo group. The secondary endpoints also showed clinically meaningful improvements, including a mean proptosis reduction of 3.17 mm at week 24 and enhanced quality-of-life scores. Other benefits included positive responses in diplopia (double vision) and clinical activity scores.

Amgen Inc. (NASDAQ:AMGN) leadership noted that this subcutaneous option could evolve the standard of care by offering a more convenient and accessible delivery method for the 25,000+ patients who have historically relied on IV infusions. The safety profile for the subcutaneous administration was generally consistent with the established IV profile, with the addition of mild-to-moderate injection site reactions.

Amgen Inc. (NASDAQ:AMGN) is a drug manufacturer that delivers human therapeutics through pharmaceutical wholesale distributors. The company was founded in 1980 and is headquartered in California.